Topics

The Mesothelioma Applied Research Foundation Company Profile

22:06 EDT 5th April 2020 | BioPortfolio

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.


News Articles [977 Associated News Articles listed on BioPortfolio]

Study uncovers novel targetable axis in mesothelioma patients

A collaborative study of researchers from Thomas Jefferson University, Sbarro Institute for Cancer Research and Molecular Medicine of Temple University, University of Siena, and from the Spanish Cente...

Two-drug combination could be effective against malignant mesothelioma

Exposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggressive cancer that mostly affects the pleura - the tissue that lines the lungs - and the peritoneum - the tissue...

2019 Malignant Mesothelioma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Malignant Mesothelioma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Malignant Mesothelioma. It presents indepth anal...

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel

2019 Malignant Pleural Mesothelioma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Malignant Pleural Mesothelioma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Malignant Pleural Mesothelioma. It prese...

2019 Malignant Mesothelioma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1529

The global clinical trial report 2019 Malignant Mesothelioma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Malignant Mesothelioma. It presents indepth anal...

2019 Malignant Mesothelioma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1583

The global clinical trial report 2019 Malignant Mesothelioma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Malignant Mesothelioma. It presents indepth anal...

2019 Malignant Mesothelioma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1799

The global clinical trial report 2019 Malignant Mesothelioma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Malignant Mesothelioma. It presents indepth anal...

PubMed Articles [1734 Associated PubMed Articles listed on BioPortfolio]

Workshop summary: Potential usefulness and feasibility of a US national mesothelioma registry.

The burden and prognosis of malignant mesothelioma in the United States have remained largely unchanged for decades, with approximately 3200 new cases and 2400 deaths reported annually. To address car...

Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.

Detailed guidelines pertaining to radiological assessment of malignant pleural mesothelioma (MPM) are currently lacking due to the rarity of the disease, complex morphology, propensity to invade multi...

18F-FDG PET/CT Findings of Ovarian Mesothelioma: A Case Study.

Ovarian mesothelioma is a rare and aggressive tumor. Early diagnosis of the disease is difficult, delaying effective treatment. Here we report a 50-year-old woman who was referred for an F-FDG PET/CT ...

Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells.

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is overexpressed in a subset of malignant cells. However, it remains unknown whether ROR1 is targetable in malignant mesothelioma (MM). Therefore...

Mesothelioma Associated with the Use of Cosmetic Talc.

To describe exposures to talcum powder leading to mesothelioma among 33 individuals as a non-occupational asbestos exposure.

Clinical Trials [4071 Associated Clinical Trials listed on BioPortfolio]

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

MiST is a British Lung Foundation funded, University of Leicester Study, a multi-arm stratified therapy based clinical trial for patients with relapsed mesothelioma. The goal of MiST is t...

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers relate...

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

For patients with malignant pleural mesothelioma that has grown despite treatment with standard chemotherapy, no treatment has yet proven beneficial. The purpose of this study is to find o...

SU5416 in Treating Patients With Malignant Mesothelioma

RATIONALE: SU5416 may stop the growth of malignant mesothelioma by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who ...

Companies [3077 Associated Companies listed on BioPortfolio]

The Mesothelioma Applied Research Foundation

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively...

Mesothelioma Applied Research Foundation

Baron & Budd, P.C. .

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As ...

Simmons Firm

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

More Information about "The Mesothelioma Applied Research Foundation" on BioPortfolio

We have published hundreds of The Mesothelioma Applied Research Foundation news stories on BioPortfolio along with dozens of The Mesothelioma Applied Research Foundation Clinical Trials and PubMed Articles about The Mesothelioma Applied Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Mesothelioma Applied Research Foundation Companies in our database. You can also find out about relevant The Mesothelioma Applied Research Foundation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record